ArticleFrontiers in psychology2024
Diagnostic accuracy and clinical utility of the PHQ-2 and GAD-2: a comparison with long-format measures for depression and anxiety.
Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05016843 (The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression), which is not on this map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression ("TRAnsdiagnostisk BEhandling (Elektronisk)")
Who cites it
32 citing papers in PubMed.
- The Arabic Generalized Anxiety Disorder 2 (GAD-2): Psychometric evaluation among mothers of children with intellectual disabilities.Dialogues in clinical neuroscience · 2026Article
- Article
- Anna vs. Judith: A randomized comparison of AI-delivered psychodynamic and cognitive behavioral therapies for social anxiety disorder.Internet interventions · 2026Article
- Internet-delivered unguided psychodynamic vs. cognitive behavior therapy for anxiety and depression symptoms: A large, full factorial randomized controlled trial on treatment length and peer support.Internet interventions · 2026Article
- The Relationship Between Loneliness and Sleep Disturbances: The Roles of Community Resilience, Social Support, Anxiety, and Substance Use Coping.International journal of environmental research and public health · 2026Article
- Impact of chronic pain on the families of U.S. adults.Pain reports · 2026Article
- Psychometric assessment and exploratory scale refinement of the Generalized Anxiety Disorder 7-item scale among adolescents and young adults in a Swedish context.BMC psychiatry · 2026Article
- Using Ultra-Abridged Individual Difference Scales for Personalization in Digital Mental Health to Improve Uptake, Engagement, and Experiences: Three-Tiered Decision Framework for Scale Shortening.Journal of medical Internet research · 2026Article
- Social support as the protector of mental health during the COVID-19 pandemic: Population-based longitudinal evidence across pre- and post-vaccine phases.Social psychiatry and psychiatric epidemiology · 2026Article
- Psychometric validation of the Arabic WHO Ageism Experiences Scale in Libya: evidence from a humanitarian context.Age and ageing · 2026Article
- Association of performance status, depression, and demographics with advance directive documentation in patients with glioblastoma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Depression and social media addiction among teenagers in a longitudinal study with dual moderation.Scientific reports · 2026Article
- Impact of Multimorbidity on Mental Illness in the United Arab Emirates: A Review.Journal of multidisciplinary healthcare · 2026Review
- Prevalence of burnout syndrome and associated factors among nurses in Mogadishu, Somalia: a multicenter cross-sectional study.Frontiers in public health · 2026Article
- Prevalence and factors associated with mental distress among men at higher risk of HIV infection enrolled in an HIV pre-exposure prophylaxis program in Tanga, Tanzania.Frontiers in psychiatry · 2026Article
- Bed bug infestations: prevalence, correlates, and cross-sectional association with psychological symptoms in a large sample of tenants in Montreal, Canada.BMC public health · 2025Article
- Mental health during and after the COVID-19 pandemic - a longitudinal study over 42 months in five European countries.European journal of psychotraumatology · 2025Article
- Predictors of impaired awareness of hypoglycaemia and severe hypoglycaemia in adults with type 1 diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
- Ambient and Bedroom Heat in Relation to Sleep Health in a Marginalized Community That Is One of the Hottest in Los Angeles.International journal of environmental research and public health · 2025Article
- The role of mind wandering and anxiety in the association between internet addiction and hyperactivity-impulsivity: a serial mediation model.BMC psychology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety and depression are highly prevalent and often comorbid mental disorders that are encompassed within the broad category of emotional disorders. The frequent comorbidity of anxiety and depression can pose challenges for accurate diagnosis and treatment which, in turn, highlights the need for reliable measurements that are simultaneously responsive to change and prevent non-response bias. Brief measures of anxiety and depression can potentially increase response rates due to their brevity and ease of administration. This study evaluates the psychometric characteristics, discriminative accuracy, and sensitivity to change of the Generalized Anxiety Disorder 2-item scale (GAD-2) and the Patient Health Questionnaire 2-item scale (PHQ-2) within a clinical population. Method: The sample comprised treatment-seeking participants ( Results: Brief measures can effectively detect individuals who may be eligible for a diagnosis of depression and anxiety, not only prior to but also during and following the completion of psychological treatment. The discriminative ability of the GAD-2 was significantly greater during active treatment and at post-assessment compared with pre-treatment screening, although no such differences were found for the PHQ-2. Finally, endorsing the most severe response option on the GAD-2 and PHQ-2 was associated with a high probability of presenting with clinically relevant anxiety and depressive symptoms. Conclusion: Brief measures of anxiety and depression are viable instruments to screen for and monitor anxiety and depressive symptoms. Clinical trial registration: ClinicalTrials.gov, identifier NCT05016843.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.